Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • proper noun A taxonomic genus within the family Columbidae.

Etymologies

Sorry, no etymologies found.

Examples

  • Species of particular concern are black-fronted piping guan Aburria jacutinga (E), Brazilian merganser Mergus octosetaceus (E), purple-winged ground dove Claravis godefrida (E) and helmeted woodpecker Dryocopus galeatus (V).

    Iguazú National Park, Argentina

  • The drug is manufactured by Roche Pharmaceuticals and is also marketed under the generic names Amnesteem, Claravis, Isotretinoin, and Sotret.

    Accutane - Another Case Of Too Little Too Late

  • Isotretinoin is also sold under the brand names of Accutane, Roaccutane, Amnesteem, Claravis and Sotret.

    FDA Needs To Ban Accutane

  • And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.

    Biotech Sector and Stocks Analysis from Seeking Alpha

  • Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.

    SeekingAlpha.com: Home Page

  • Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.

    Biotech Sector and Stocks Analysis from Seeking Alpha

  • And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.

    SeekingAlpha.com: Home Page

  • And we had some strong growth in some of the products that we had some pickups on Claravis and the Dex family of products because some competitors went out of the markets on those products.

    SeekingAlpha.com: Home Page

  • Our non-OC sales in North America totaled a $192 million in the September quarter, an increase of $27 million or 17\% driven by higher sales of our Dex family of products and Claravis principally due to higher market shares as a result of competitors leaving the markets or exiting the markets under those products as well as higher sales of Vitamin D due to higher demand.

    SeekingAlpha.com: Home Page

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.